fairfaxnews.com
Opana ER being pulled because of opioid abuse
Endo Pharmaceuticals today bowed to the FDA’s June 2017 request that it pull Opana ER from the marketplace, on the grounds that the opioid drug’s potential for abuse and misuse far outw…